Koyfin Home > Directory > Health Care > Nymox Pharm Corp > Long-Term Debt

Nymox Pharm Corp Long-Term Debt Chart (NYMX)

Nymox Pharm Corp annual/quarterly Long-Term Debt from 2014 to 2017.
  • Nymox Pharm Corp Long-Term Debt for the quarter ending March 03, 2017 was $1m a 12.76% increase of 0m year over year
  • Nymox Pharm Corp Long-Term Debt for the last 12 months ending March 03, 2017 was $1m a 12.76% increase of 0m year over year
Other Cash Flow Metrics:
  • Nymox Pharm Corp Cash Flow from Operations for the quarter ending September 09, 2018 was $-2m a 46.48% decrease of -1m year over year
  • Nymox Pharm Corp Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-1m a 97.41% decrease of -1m year over year
  • Nymox Pharm Corp Total Revenue for the quarter ending September 09, 2018 was $0m a -163.24% decrease of 0m year over year
View Chart On Koyfin

Quarterly NYMX Long-Term Debt Data

03/2017$1m
09/2016$1m
06/2016$1m
03/2016$1m
12/2015$1m
09/2015$1m
06/2015$1m
03/2015$1m
12/2014$1m

Annual NYMX Long-Term Debt Data

2014$1m